Minocycline-induced lupus - A systematic review

被引:65
|
作者
Schlienger, RG [1 ]
Bircher, AJ
Meier, CR
机构
[1] Univ Basel Hosp, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Div Dermatol, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Pharm, Inst Pharmacotherapy, CH-4003 Basel, Switzerland
[4] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
关键词
minocycline; auto-immune diseases; drug-induced lupus;
D O I
10.1159/000018387
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Minocycline has increasingly been associated with different adverse auto-immune reactions including drug-induced lupus, Objective: To identify the scope of minocycline-induced lupus and to characterise its typical features. Methods: Comprehensive Medline and Embase search of the English and non-English literature for case reports of minocyctine-induced lupus. Results: We included 57 cases of minocycline-induced lupus (mean age +/- SD at onset: 21.6 +/- 8.6 years, median time of exposure: 19 months, range 3 days to 6 years). All patients showed the clinical features of polyarthralgia/ polyarthritis often accompanied by liver abnormalities. Twelve patients had evidence of dermatological manifestations (i.e rash, livedo reticularis, oral ulceration, subcutaneous nodules, alopecia). The ANA test was positive in all patients. Conclusion: Long-term exposure to minocycline may be associated with drug-induced lupus. Baseline and periodic liver function and ANA tests accompanied by appropriate clinical monitoring are suggested for patients receiving long-term minocycline therapy. Copyright (C) 2000 S. Karger AG,Basel.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [21] Minocycline-induced cutaneous polyarteritis nodosa
    Tehrani, Rodney
    Nash-Goelitz, Alyssa
    Adams, Elaine
    Dahiya, Madhu
    Eilers, David
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (03) : 146 - 149
  • [22] Minocycline-Induced Hyperpigmentation in Multibacillary Leprosy
    Hu, Stephanie W.
    Robinson, Maria R.
    Newlove, Tracey
    Meehan, Shane
    Levis, William R.
    Patel, Rishi R.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (08) : E114 - E118
  • [23] Minocycline-induced hyperpigmentation in rheumatoid arthritis
    Fay, Brian T.
    Whiddon, Annemarie P.
    Puumala, Susan
    Black, Natalie A.
    O'Dell, James R.
    Mikuls, Ted R.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (01) : 17 - 20
  • [24] Minocycline-Induced Scleral and Dermal Hyperpigmentation
    Haskes, Cheryl
    Shea, Michael
    Imondi, David
    OPTOMETRY AND VISION SCIENCE, 2017, 94 (03) : 436 - 442
  • [25] Minocycline-Induced PigmentationIncidence, Prevention and Management
    Drore Eisen
    Miriam D. Hakim
    Drug Safety, 1998, 18 : 431 - 440
  • [26] Minocycline-induced pancreatitis in cystic fibrosis
    Boyle, MP
    CHEST, 2001, 119 (04) : 1283 - 1285
  • [27] Minocycline-Induced Skin Pigmentation: An Update
    Geria, Aanand N.
    Tajirian, Ani L.
    Kihiczak, George
    Schwartz, Robert A.
    ACTA DERMATOVENEROLOGICA CROATICA, 2009, 17 (02) : 123 - 126
  • [28] Minocycline-induced lupus and autoimmune hepatitis: Family autoimmune disorders as possible risk factors
    Bachmeyer, C
    Cadranel, JF
    DERMATOLOGY, 2002, 205 (02) : 185 - 186
  • [29] Minocycline-induced acute eosinophilic pneumonia: A case report and review of the literature
    Hung, Sharon W.
    RESPIRATORY MEDICINE CASE REPORTS, 2015, 15 : 110 - 114
  • [30] Minocycline-induced pigmentation of basal cell carcinomas
    Butt, A
    Das, KB
    Statham, BN
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 (01) : 39 - 40